Cross-fund · 4 holders
XERS
XERIS BIOPHARMA HOLDINGS INC
CUSIP 98422E103
4
Tracked holders
$180.4M
Aggregate value
27,145,670
Shares
5
Active funds
Funds holding XERS
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $87.8M | — | +1,358,760 | +13.8% |
| BlackRock | Institutional | Q1 2026 | $75.1M | — | +306,467 | +2.4% |
| Millennium | Multi-Strategy | Q1 2026 | $13.1M | 0.01% | +1,406,923 | +163.8% |
| Citadel | Multi-Strategy | Q1 2026 | $4.3M | — | +306,314 | +69.5% |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | -608,080 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.